ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Order Full text via Infotrieve
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vergeret, J
Right arrow Articles by Mounier, L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vergeret, J
Right arrow Articles by Mounier, L
Eur Respir J 1989; 2: 20-25
Copyright © ERS Journals Ltd 1989


Clinical Trial

Portable oxygen therapy: use and benefit in hypoxaemic COPD patients on long-term oxygen therapy

J Vergeret, C Brambilla, and L Mounier

In 159 chronic obstructive pulmonary disease (COPD) patients (139 males, mean age 62 +/- 8 yrs, arterial oxygen tension (PaO2) 7.2 +/- 0.9 kPa), on long-term oxygen therapy (LTOT), we evaluated the effects of portable oxygen therapy both on the daily duration of oxygen therapy and on daily activities. They were given two types of LTOT at random: group A (n = 75), oxygen concentrators only (OC); group B (n = 84), either small oxygen cylinders plus OC (B1 = 51) or liquid oxygen (B2 = 33). The patients were followed-up for one year by means of: a) medical examination every three months; b) monthly home interviews concerning the daily duration of oxygen therapy, the utilization of the devices and the daily activities of the patients; c) a measurement of the daily oxygen usage. The results show that: 1) there are no significant clinical and functional differences between groups A and B at the onset of and throughout the study; 2) in group B the daily use of oxygen therapy is significantly longer than in group A (17 +/- 3.5 h.day-1 vs 14 +/- 3 h.day-1, p less than 0.01) without any difference between groups B1 and B2; 3) outdoor walking activities are different between groups A and B, at least in those patients using oxygen more than 18 h.day-1. Only 60% of patients in group B (55% of B1; 67% of B2) use their portable devices outdoors and for walking. No strict predictive criterion of this use is found in our study.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
ChestHome page
C. J. Sandland, M. D. L. Morgan, and S. J. Singh
Patterns of Domestic Activity and Ambulatory Oxygen Usage in COPD
Chest, October 1, 2008; 134(4): 753 - 760.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
E. Crisafulli, S. Costi, F. De Blasio, G. Biscione, F. Americi, S. Penza, E. Eutropio, F. Pasqua, L. M. Fabbri, and E. M. Clini
Effects of a Walking Aid in COPD Patients Receiving Oxygen Therapy
Chest, April 1, 2007; 131(4): 1068 - 1074.
[Abstract] [Full Text] [PDF]


Home page
Chronic Respiratory DiseaseHome page
D L Cullen
Long term oxygen therapy adherence and COPD: what we don't know
Chronic Respiratory Disease, November 1, 2006; 3(4): 217 - 222.
[Abstract] [PDF]


Home page
ThoraxHome page
J A Wedzicha and P M A Calverley
All change for home oxygen services in England and Wales
Thorax, January 1, 2006; 61(1): 7 - 9.
[Full Text] [PDF]


Home page
Eur Respir JHome page
Y. Lacasse, R. Lecours, C. Pelletier, R. Begin, and F. Maltais
Randomised trial of ambulatory oxygen in oxygen-dependent COPD
Eur. Respir. J., June 1, 2005; 25(6): 1032 - 1038.
[Abstract] [Full Text] [PDF]


Home page
Clin RehabilHome page
T. J Ringbaek and P. Lange
Outdoor activity and performance status as predictors of survival in hypoxaemic chronic obstructive pulmonary disease (COPD)
Clinical Rehabilitation, March 1, 2005; 19(3): 331 - 338.
[Abstract] [PDF]


Home page
ChestHome page
A. Cuvelier, J.-F. Nuir, N. Chakroun, J. Aboab, G. Onea, and D. Benhamou
Refillable Oxygen Cylinders May Be an Alternative for Ambulatory Oxygen Therapy in COPD*
Chest, August 1, 2002; 122(2): 451 - 456.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
A. Cuvelier, J.-F. Muir, P. Czernichow, E. Vavasseur, F. Portier, D. Benhamou, and D. Samson-Dolfuss
Nocturnal Efficiency and Tolerance of a Demand Oxygen Delivery System in COPD Patients With Nocturnal Hypoxemia
Chest, July 1, 1999; 116(1): 22 - 29.
[Abstract] [Full Text] [PDF]


Home page
Journal of Pharmacy PracticeHome page
G. R. DeYoung, P. L. Vetter, and W. A. Kradjan
The Pharmacological Treatment of Ambulatory Chronic Obstructive Pulmonary Disease Patients
Journal of Pharmacy Practice, January 1, 1992; 5(4): 204 - 216.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by the European Respiratory Society.